1-4-methylumbelliferone and interleukin-12 combined therapy inhibit tumor growth by inducing antitumor immunity and reducing the presence of cancer stem cells in an murine hepatocellular carcinoma model associated with fibrosis.

RODRIGUEZ M; GARCIA M; PEIXOTO E; MALVICINI M; BAYO J; ATORRASAGASTI C; FIORE E; GOMEZ BUSTILLO S; MAZZOLINI G.

Nueva York

Congreso; Conferencia Internacional de Inmunoterapia; 2016

*